Pravastatin for lowering lipids

Pravastatin for lowering lipids

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objective To learn more about the pharmacology of pravastatin by characterizing the dose‐related effect and variability of the effect of pravastatin on the surrogate marker: low‐density lipoprotein (LDL c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane database of systematic reviews 2020-07, Vol.2020 (7)
Hauptverfasser: Adams, Stephen P, Alaeiilkhchi, Nima, Tasnim, Sara, Wright, James M
Format: Artikel
Sprache:eng
Schlagworte:
Heart & circulation
Treatment of essential Hypertension
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page
container_title Cochrane database of systematic reviews
container_volume 2020
creator Adams, Stephen P
Alaeiilkhchi, Nima
Tasnim, Sara
Wright, James M
description This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objective To learn more about the pharmacology of pravastatin by characterizing the dose‐related effect and variability of the effect of pravastatin on the surrogate marker: low‐density lipoprotein (LDL cholesterol). The effects of statins on morbidity and mortality is not the objective of this systematic review. Secondary objectives To characterize the dose‐related effect and variability of effect of pravastatin on the following surrogate markers: total cholesterol; high‐density lipoprotein (HDL cholesterol); and triglycerides. To quantify the effect of various doses of pravastatin on withdrawals due to adverse effects.
doi_str_mv 10.1002/14651858.CD013673
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7387836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_7387836</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2583-1713b4669d1cc21baca1d29766b9f03d4fe55f5a8675368a22445bd27a8ab6743</originalsourceid><addsrcrecordid>eNpVkM1Kw0AUhQdRsFYfwJV5gdT5n8lGkGhVKOhC18PN_NSRNAkzseLba6gVXZ3Dudxv8SF0TvCCYEwvCZeCaKEX9Q0mTCp2gGbTVk7j4Z9-jE5yfsOYyYqqGbp4SrCFPMIYuyL0qWj7D59ity7aOESXT9FRgDb7s5-co5fl7XN9X64e7x7q61VpqdCsJIqwhktZOWItJQ1YII5WSsqmCpg5HrwQQYCWSjCpgVLOReOoAg2NVJzN0dWOO7w3G--s78YErRlS3ED6ND1E8__SxVez7rdGMa00k98AsgPY1OecfPj9JdhMisxekdkrYl-vWFk7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pravastatin for lowering lipids</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Cochrane Library</source><source>Alma/SFX Local Collection</source><creator>Adams, Stephen P ; Alaeiilkhchi, Nima ; Tasnim, Sara ; Wright, James M</creator><creatorcontrib>Adams, Stephen P ; Alaeiilkhchi, Nima ; Tasnim, Sara ; Wright, James M</creatorcontrib><description>This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objective To learn more about the pharmacology of pravastatin by characterizing the dose‐related effect and variability of the effect of pravastatin on the surrogate marker: low‐density lipoprotein (LDL cholesterol). The effects of statins on morbidity and mortality is not the objective of this systematic review. Secondary objectives To characterize the dose‐related effect and variability of effect of pravastatin on the following surrogate markers: total cholesterol; high‐density lipoprotein (HDL cholesterol); and triglycerides. To quantify the effect of various doses of pravastatin on withdrawals due to adverse effects.</description><identifier>ISSN: 1465-1858</identifier><identifier>EISSN: 1465-1858</identifier><identifier>EISSN: 1469-493X</identifier><identifier>DOI: 10.1002/14651858.CD013673</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Heart &amp; circulation ; Treatment of essential Hypertension</subject><ispartof>Cochrane database of systematic reviews, 2020-07, Vol.2020 (7)</ispartof><rights>Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2583-1713b4669d1cc21baca1d29766b9f03d4fe55f5a8675368a22445bd27a8ab6743</citedby><cites>FETCH-LOGICAL-c2583-1713b4669d1cc21baca1d29766b9f03d4fe55f5a8675368a22445bd27a8ab6743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids></links><search><creatorcontrib>Adams, Stephen P</creatorcontrib><creatorcontrib>Alaeiilkhchi, Nima</creatorcontrib><creatorcontrib>Tasnim, Sara</creatorcontrib><creatorcontrib>Wright, James M</creatorcontrib><title>Pravastatin for lowering lipids</title><title>Cochrane database of systematic reviews</title><description>This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objective To learn more about the pharmacology of pravastatin by characterizing the dose‐related effect and variability of the effect of pravastatin on the surrogate marker: low‐density lipoprotein (LDL cholesterol). The effects of statins on morbidity and mortality is not the objective of this systematic review. Secondary objectives To characterize the dose‐related effect and variability of effect of pravastatin on the following surrogate markers: total cholesterol; high‐density lipoprotein (HDL cholesterol); and triglycerides. To quantify the effect of various doses of pravastatin on withdrawals due to adverse effects.</description><subject>Heart &amp; circulation</subject><subject>Treatment of essential Hypertension</subject><issn>1465-1858</issn><issn>1465-1858</issn><issn>1469-493X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkM1Kw0AUhQdRsFYfwJV5gdT5n8lGkGhVKOhC18PN_NSRNAkzseLba6gVXZ3Dudxv8SF0TvCCYEwvCZeCaKEX9Q0mTCp2gGbTVk7j4Z9-jE5yfsOYyYqqGbp4SrCFPMIYuyL0qWj7D59ity7aOESXT9FRgDb7s5-co5fl7XN9X64e7x7q61VpqdCsJIqwhktZOWItJQ1YII5WSsqmCpg5HrwQQYCWSjCpgVLOReOoAg2NVJzN0dWOO7w3G--s78YErRlS3ED6ND1E8__SxVez7rdGMa00k98AsgPY1OecfPj9JdhMisxekdkrYl-vWFk7</recordid><startdate>20200709</startdate><enddate>20200709</enddate><creator>Adams, Stephen P</creator><creator>Alaeiilkhchi, Nima</creator><creator>Tasnim, Sara</creator><creator>Wright, James M</creator><general>John Wiley &amp; Sons, Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20200709</creationdate><title>Pravastatin for lowering lipids</title><author>Adams, Stephen P ; Alaeiilkhchi, Nima ; Tasnim, Sara ; Wright, James M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2583-1713b4669d1cc21baca1d29766b9f03d4fe55f5a8675368a22445bd27a8ab6743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Heart &amp; circulation</topic><topic>Treatment of essential Hypertension</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adams, Stephen P</creatorcontrib><creatorcontrib>Alaeiilkhchi, Nima</creatorcontrib><creatorcontrib>Tasnim, Sara</creatorcontrib><creatorcontrib>Wright, James M</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cochrane database of systematic reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adams, Stephen P</au><au>Alaeiilkhchi, Nima</au><au>Tasnim, Sara</au><au>Wright, James M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pravastatin for lowering lipids</atitle><jtitle>Cochrane database of systematic reviews</jtitle><date>2020-07-09</date><risdate>2020</risdate><volume>2020</volume><issue>7</issue><issn>1465-1858</issn><eissn>1465-1858</eissn><eissn>1469-493X</eissn><abstract>This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objective To learn more about the pharmacology of pravastatin by characterizing the dose‐related effect and variability of the effect of pravastatin on the surrogate marker: low‐density lipoprotein (LDL cholesterol). The effects of statins on morbidity and mortality is not the objective of this systematic review. Secondary objectives To characterize the dose‐related effect and variability of effect of pravastatin on the following surrogate markers: total cholesterol; high‐density lipoprotein (HDL cholesterol); and triglycerides. To quantify the effect of various doses of pravastatin on withdrawals due to adverse effects.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><doi>10.1002/14651858.CD013673</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1465-1858
ispartof Cochrane database of systematic reviews, 2020-07, Vol.2020 (7)
issn 1465-1858
1465-1858
1469-493X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7387836
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Cochrane Library; Alma/SFX Local Collection
subjects Heart & circulation
Treatment of essential Hypertension
title Pravastatin for lowering lipids
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T18%3A24%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pravastatin%20for%20lowering%20lipids&rft.jtitle=Cochrane%20database%20of%20systematic%20reviews&rft.au=Adams,%20Stephen%20P&rft.date=2020-07-09&rft.volume=2020&rft.issue=7&rft.issn=1465-1858&rft.eissn=1465-1858&rft_id=info:doi/10.1002/14651858.CD013673&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_7387836%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true